Lectin-mediated transport of nanoparticles across Caco-2 and OK cells

被引:95
|
作者
Russell-Jones, GJ
Veitch, H
Arthur, L
机构
[1] Biotech Australia Pty Ltd, Roseville, NSW 2069, Australia
[2] Westmead Hosp, Sydney, NSW, Australia
关键词
lectin; Caco-2; OK; nanoparticles; oral drug delivery;
D O I
10.1016/S0378-5173(99)00254-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent experiments by a number of workers have suggested that it may be possible to use various targeting molecules, which bind to the intestinal epithelium, to promote the uptake and transport of nanoparticles from the intestine to the circulation. We have used commercial nanoparticles to examine the effect of size, density and inhibitors on uptake of lectin-coated nanoparticles by epithelial cells. The degree of uptake was most influenced by the density of lectin on the particle, with size and type of lectin being less important. Uptake could be inhibited by the presence of specific sugars or free lectin. These studies should provide a good basis for the design of targetable biodegradable drug-loadable particles suitable for oral delivery. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:165 / 174
页数:10
相关论文
共 50 条
  • [1] Vitamin B12-mediated transport of nanoparticles across Caco-2 cells
    Russell-Jones, GJ
    Arthur, L
    Walker, H
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (02) : 247 - 255
  • [2] Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells
    Ogihara, T
    Tamai, I
    Takanaga, H
    Sai, Y
    Tsuji, A
    PHARMACEUTICAL RESEARCH, 1996, 13 (12) : 1828 - 1832
  • [3] Transport of parthenolide across human intestinal cells (Caco-2)
    Khan, SI
    Abourashed, EA
    Khan, IA
    Walker, LA
    PLANTA MEDICA, 2003, 69 (11) : 1009 - 1012
  • [4] Physicochemical Properties and Transport of Steroids Across Caco-2 Cells
    Fried Faassen
    Jan Kelder
    Johan Lenders
    Rob Onderwater
    Herman Vromans
    Pharmaceutical Research, 2003, 20 : 177 - 186
  • [5] Ergovaline transport across human gastrointestinal cells (Caco-2)
    Shappell, N. W.
    Smith, D. J.
    POULTRY SCIENCE, 2004, 83 : 181 - 181
  • [6] Ergovaline transport across human gastrointestinal cells (Caco-2)
    Shappell, N. W.
    Smith, D. J.
    JOURNAL OF DAIRY SCIENCE, 2004, 87 : 181 - 181
  • [7] Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model
    Gabor, F
    Schwarzbauer, A
    Wirth, M
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) : 227 - 239
  • [8] Physicochemical properties and transport of steroids across Caco-2 cells
    Faassen, F
    Kelder, J
    Lenders, J
    Onderwater, R
    Vromans, H
    PHARMACEUTICAL RESEARCH, 2003, 20 (02) : 177 - 186
  • [9] THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS
    CONRADI, RA
    HILGERS, AR
    HO, NFH
    BURTON, PS
    PHARMACEUTICAL RESEARCH, 1991, 8 (12) : 1453 - 1460
  • [10] Ergovaline transport across human gastrointestinal cells (Caco-2)
    Shappell, N. W.
    Smith, D. J.
    JOURNAL OF ANIMAL SCIENCE, 2004, 82 : 181 - 181